Investigating how a specific enzyme influences the transformation of blood cancer.
Project 3: Role of stromal cell-activated CNOT6L deadenylase in driving AML transformation
This study is looking at how a specific enzyme called CNOT6L might play a role in the development of acute myeloid leukemia from a related condition called myelodysplastic syndromes, and it aims to find out if changing the levels of this enzyme could help improve treatment options for patients.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10935671 on NIH RePORTER |
What this research studies
This research explores the role of the CNOT6L deadenylase enzyme in the development of acute myeloid leukemia (AML) from myelodysplastic syndromes (MDS). It focuses on how the bone marrow's stromal microenvironment contributes to the progression of these blood cancers. By using models and patient samples, the study aims to understand the mechanisms behind AML transformation and how manipulating CNOT6L levels can affect disease outcomes. Patients may benefit from insights that could lead to new treatment strategies targeting this enzyme.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients diagnosed with myelodysplastic syndromes who are at risk of developing acute myeloid leukemia.
Not a fit: Patients with other types of blood cancers or those without myelodysplastic syndromes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to novel therapies that prevent or reverse the progression of AML in patients with MDS.
How similar studies have performed: Previous research has shown promising results in targeting similar pathways in blood cancers, indicating potential for success in this approach.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Kousteni, Stavroula — Columbia University Health Sciences
- Study coordinator: Kousteni, Stavroula
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.